Kenneth S. Boger
2009
Compensation breakdown
Non-Equity Incentive Plan | $324,613 |
---|---|
Option Awards | $2,056,972 |
Salary | $426,214 |
Stock Awards | $340,968 |
Other | $12,316 |
Total | $3,161,083 |
Boger received $2.1M in option awards, accounting for 65% of the total pay in 2009.
Boger also received $324.6K in non-equity incentive plan, $426.2K in salary, $341K in stock awards and $12.3K in other compensation.
Rankings
In 2009, Kenneth S. Boger's compensation ranked 1,424th out of 9,885 executives tracked by ExecPay. In other words, Boger earned more than 85.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,424 | 86th |
Manufacturing | 508 | 86th |
Chemicals And Allied Products | 103 | 88th |
Drugs | 68 | 89th |
Pharmaceutical Preparations | 55 | 88th |
Boger's colleagues
We found six more compensation records of executives who worked with Kenneth S. Boger at Vertex Pharmaceuticals in 2009.
2009
Matthew Emmens
Vertex Pharmaceuticals
Chief Executive Officer
2009
Nancy Wysenski
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2009
Joshua Boger
Vertex Pharmaceuticals
Chief Executive Officer
2009
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2009
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2009
Amit Sachdev
Vertex Pharmaceuticals